These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15082464)

  • 1. A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate.
    Hammarberg A; Wennberg P; Beck O; Franck J
    Alcohol Alcohol; 2004; 39(3):251-5. PubMed ID: 15082464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
    De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
    Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
    Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.
    Reid SC; Teesson M; Sannibale C; Matsuda M; Haber PS
    J Stud Alcohol; 2005 Nov; 66(6):833-41. PubMed ID: 16459945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
    Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
    Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
    Chick J; Howlett H; Morgan MY; Ritson B
    Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
    Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
    Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
    Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
    Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
    Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
    Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.